News headlines about Phibro Animal Health (NASDAQ:PAHC) have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Phibro Animal Health earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.0329461911863 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news articles that may have effected Accern’s analysis:
PAHC has been the subject of a number of analyst reports. ValuEngine upgraded shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Wednesday, February 28th. BidaskClub upgraded shares of Phibro Animal Health from a “strong sell” rating to a “sell” rating in a research report on Saturday, January 6th. Morgan Stanley upped their price objective on shares of Phibro Animal Health from $30.00 to $36.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 7th. Piper Jaffray Companies reiterated a “buy” rating and issued a $42.00 price objective on shares of Phibro Animal Health in a research report on Friday, November 10th. Finally, Credit Suisse Group upped their price objective on shares of Phibro Animal Health from $37.00 to $39.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 6th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. Phibro Animal Health has a consensus rating of “Hold” and an average price target of $38.20.
Phibro Animal Health (NASDAQ PAHC) opened at $38.90 on Wednesday. The firm has a market cap of $1,589.55, a PE ratio of 25.43, a price-to-earnings-growth ratio of 2.81 and a beta of 0.97. Phibro Animal Health has a 1 year low of $26.70 and a 1 year high of $40.25. The company has a debt-to-equity ratio of 1.82, a current ratio of 3.12 and a quick ratio of 1.75.
Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Monday, February 5th. The company reported $0.44 earnings per share for the quarter, topping analysts’ consensus estimates of $0.38 by $0.06. The business had revenue of $205.90 million during the quarter, compared to the consensus estimate of $194.90 million. Phibro Animal Health had a net margin of 7.90% and a return on equity of 40.49%. The company’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.39 earnings per share. sell-side analysts expect that Phibro Animal Health will post 1.69 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 28th. Shareholders of record on Wednesday, March 7th will be given a $0.10 dividend. The ex-dividend date is Tuesday, March 6th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.03%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 26.14%.
In related news, insider Dean J. Warras sold 10,000 shares of the company’s stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $35.62, for a total transaction of $356,200.00. Following the completion of the transaction, the insider now owns 10,000 shares in the company, valued at approximately $356,200. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jack Bendheim sold 36,000 shares of the company’s stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $38.35, for a total transaction of $1,380,600.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 156,358 shares of company stock valued at $5,760,665. Insiders own 51.88% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.